I wonder if last Friday's short attack was a complete failure and Shorts got stuck in a short position they didn't want. 2.9 million shares were sold and the stock price dropped less than $2. I'm sure they anticipated the stock price dropping further. They immediately bought back sending the stock price shooting up to $15.40. Far more shares were sold than rebought. So they might have still been short at the end of trading Friday. At some point, they'll need to buy shares to cover their position. Hopefully, some of them are now researching lenzilumab and realizing that they don't want to be short this stock when data comes out. GM-CSF baby!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.